Reference
1. Heba AC, Toupance S, Arnone D, Peyrin-Biroulet L, Benetos A, Ndiaye NC. Telomeres: New Players in Immune-Mediated Inflammatory Diseases? J Autoimmun (2021) 123:102699. Epub 2021/07/16. doi: 10.1016/j.jaut.2021.102699.
2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The Hallmarks of Aging. Cell (2013) 153(6):1194-217. Epub 2013/06/12. doi: 10.1016/j.cell.2013.05.039.
3. Weng NP. Telomeres and Immune Competency. Curr Opin Immunol (2012) 24(4):470-5. Epub 2012/05/26. doi: 10.1016/j.coi.2012.05.001.
4. Maecker HT, McCoy JP, Nussenblatt R. Standardizing Immunophenotyping for the Human Immunology Project.Nat Rev Immunol (2012) 12(3):191-200. Epub 2012/02/22. doi: 10.1038/nri3158.
5. Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo JA, Lepelletier Y, Gabet AS, et al. The Telomere/Telomerase System in Autoimmune and Systemic Immune-Mediated Diseases. Autoimmun Rev (2010) 9(10):646-51. Epub 2010/05/04. doi: 10.1016/j.autrev.2010.04.004.
6. López-Otín C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-Hallmarks of Aging and Cancer.Cell Metab (2023) 35(1):12-35. Epub 2023/01/05. doi: 10.1016/j.cmet.2022.11.001.
7. Schratz KE, Flasch DA, Atik CC, Cosner ZL, Blackford AL, Yang W, et al. T Cell Immune Deficiency Rather Than Chromosome Instability Predisposes Patients with Short Telomere Syndromes to Squamous Cancers. Cancer Cell (2023) 41(4):807-17.e6. Epub 2023/04/11. doi: 10.1016/j.ccell.2023.03.005.
8. DeBoy EA, Tassia MG, Schratz KE, Yan SM, Cosner ZL, McNally EJ, et al. Familial Clonal Hematopoiesis in a Long Telomere Syndrome. N Engl J Med (2023) 388(26):2422-33. Epub 2023/05/04. doi: 10.1056/NEJMoa2300503.
9. Davies NM, Holmes MV, Davey Smith G. Reading Mendelian Randomisation Studies: A Guide, Glossary, and Checklist for Clinicians. Bmj (2018) 362:k601. Epub 2018/07/14. doi: 10.1136/bmj.k601.
10. Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomisation (Strobe-Mr): Explanation and Elaboration. Bmj(2021) 375:n2233. Epub 2021/10/28. doi: 10.1136/bmj.n2233.
11. Davey Smith G, Ebrahim S. What Can Mendelian Randomisation Tell Us About Modifiable Behavioural and Environmental Exposures? Bmj (2005) 330(7499):1076-9. Epub 2005/05/10. doi: 10.1136/bmj.330.7499.1076.
12. Codd V, Wang Q, Allara E, Musicha C, Kaptoge S, Stoma S, et al. Polygenic Basis and Biomedical Consequences of Telomere Length Variation. Nat Genet (2021) 53(10):1425-33. Epub 2021/10/07. doi: 10.1038/s41588-021-00944-6.
13. Orrù V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, et al. Complex Genetic Signatures in Immune Cells Underlie Autoimmunity and Inform Therapy. Nat Genet (2020) 52(10):1036-45. Epub 2020/09/16. doi: 10.1038/s41588-020-0684-4.
14. Burgess S, Thompson SG. Avoiding Bias from Weak Instruments in Mendelian Randomization Studies. Int J Epidemiol (2011) 40(3):755-64. Epub 2011/03/19. doi: 10.1093/ije/dyr036.
15. Bowden J, Spiller W, Del Greco MF, Sheehan N, Thompson J, Minelli C, et al. Improving the Visualization, Interpretation and Analysis of Two-Sample Summary Data Mendelian Randomization Via the Radial Plot and Radial Regression.Int J Epidemiol (2018) 47(4):1264-78. Epub 2018/07/03. doi: 10.1093/ije/dyy101.
16. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol (2016) 40(4):304-14. Epub 2016/04/12. doi: 10.1002/gepi.21965.
17. Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiology (2017) 28(1):30-42. Epub 2016/10/18. doi: 10.1097/ede.0000000000000559.
18. Bowden J, Davey Smith G, Burgess S. Mendelian Randomization with Invalid Instruments: Effect Estimation and Bias Detection through Egger Regression. Int J Epidemiol(2015) 44(2):512-25. Epub 2015/06/08. doi: 10.1093/ije/dyv080.
19. Pereira TV, Patsopoulos NA, Salanti G, Ioannidis JP. Critical Interpretation of Cochran’s Q Test Depends on Power and Prior Assumptions About Heterogeneity. Res Synth Methods (2010) 1(2):149-61. Epub 2010/04/01. doi: 10.1002/jrsm.13.
20. Verbanck M, Chen CY, Neale B, Do R. Detection of Widespread Horizontal Pleiotropy in Causal Relationships Inferred from Mendelian Randomization between Complex Traits and Diseases. Nat Genet (2018) 50(5):693-8. Epub 2018/04/25. doi: 10.1038/s41588-018-0099-7.
21. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The Mr-Base Platform Supports Systematic Causal Inference across the Human Phenome. Elife(2018) 7. Epub 2018/05/31. doi: 10.7554/eLife.34408.
22. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Ibrahim JG, et al. Expression of P16(Ink4a) in Peripheral Blood T-Cells Is a Biomarker of Human Aging. Aging Cell (2009) 8(4):439-48. Epub 2009/06/03. doi: 10.1111/j.1474-9726.2009.00489.x.
23. Vodnala SK, Eil R, Kishton RJ, Sukumar M, Yamamoto TN, Ha NH, et al. T Cell Stemness and Dysfunction in Tumors Are Triggered by a Common Mechanism. Science (2019) 363(6434). Epub 2019/03/30. doi: 10.1126/science.aau0135.
24. Berzins SP, Smyth MJ, Baxter AG. Presumed Guilty: Natural Killer T Cell Defects and Human Disease.Nat Rev Immunol (2011) 11(2):131-42. Epub 2011/01/27. doi: 10.1038/nri2904.
25. Burton DGA, Stolzing A. Cellular Senescence: Immunosurveillance and Future Immunotherapy. Ageing Res Rev (2018) 43:17-25. Epub 2018/02/11. doi: 10.1016/j.arr.2018.02.001.
26. Togashi Y, Shitara K, Nishikawa H. Regulatory T Cells in Cancer Immunosuppression - Implications for Anticancer Therapy. Nat Rev Clin Oncol (2019) 16(6):356-71. Epub 2019/02/02. doi: 10.1038/s41571-019-0175-7.
27. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two Subsets of Memory T Lymphocytes with Distinct Homing Potentials and Effector Functions. Nature (1999) 401(6754):708-12. Epub 1999/10/28. doi: 10.1038/44385.
28. Sabatino JJ, Jr., Pröbstel AK, Zamvil SS. B Cells in Autoimmune and Neurodegenerative Central Nervous System Diseases. Nat Rev Neurosci (2019) 20(12):728-45. Epub 2019/11/13. doi: 10.1038/s41583-019-0233-2.
29. Fane M, Weeraratna AT. How the Ageing Microenvironment Influences Tumour Progression. Nat Rev Cancer (2020) 20(2):89-106. Epub 2019/12/15. doi: 10.1038/s41568-019-0222-9.